This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Ernst FR, Johnston JA, Pulgar S, He J, Ball DE, Young JK, Cooper LM.Timing of drotrecogin alfa (activated) initiation in treatment of severe sepsis: a database cohort study of hospital mortality, length of stay, and costs. Current Medical Research and Opinion 23: 235-244, No. 1, Jan 2007
Rights and permissions
About this article
Cite this article
Early initiation of drotrecogin alfa worthwhile in severe sepsis. Pharmacoecon. Outcomes News 524, 11 (2007). https://doi.org/10.2165/00151234-200705240-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705240-00027